Company began in 2001 and growing in revenues each month. Company manufactures and distributes proprietary medical devices for diabetic peripheral neuropathy and Molluscum Contagiosum. Company has proprietary nano-silver technology that it licenses and maintains an R&D department that currently has several new devices under development.